Use the search parameters below to filter talks:

Congress/Meeting: Abstract text:
Session Type: Presenter First name:
Multimedia or Abstract: Presenter Last name:
Talk Title: Presenter City:
Date (start): calendar Presenter country:
Date (end): calendar
All Authors:

2010 - TTS International Congress (Vancouver)

Living Liver Donors and Techniques

16 August 2010  /  12:14 - 13:14
101.6
Contemporaneous portal and arterial reperfusion versus portal reperfusion first during liver transplantation: a prospective randomized study
Presenter: Umberto Baccarani, Udine, Italy
Authors: Baccarani U., Rossetto A., Lorenzin D., Musolino C., Comuzzi C., Bresadola V., Adani G.
101.11
Importance of Liver Biopsy in the Selection of Living-Donors for Liver Transplantation
Presenter: Sinasi Sevmis, Ankara, Turkey
Authors: Sevmis S., Aktas S., Karakayali H., Demirhan B., Selcuk H., Haberal M.
101.9
The Pattern of Graft Volume Change After Living Donor Liver Transplantation
Presenter: Man Ki Ju, ,
Authors: Ju M., Huh K., Joo D., Choi J., Kim M., Kim S.
101.10
Liver transplantation in the presence of diffuse portal vein thrombosis: A 10 year experience with cavoportal hemitransposition.
Presenter: John Söfteland, Göteborg, Sweden
Authors: Söfteland J., Kvarnström N., Friman S., Olausson M.
101.7
Long term outcome of ex situ right lobe split grafts in Liver Transplantation
Presenter: Roberto Valente, London,
Authors: Valente R., Dar F., Cherian T., Jassem W., O'Grady j., Agarwal K., Aluvihare V., Heneghan M., Suddle A., Vilca Melendez H., Prachalias A., Srinivasan P., Rela M., Heaton N.
101.8
Prevention of ischemic type biliary lesions by arterial first reperfusion in orthotopic liver transplantation
Presenter: Frank Ulrich, Frankfurt/Main, Germany
Authors: Ulrich F., Kohler S., Hofmann W., Sarrazin C., Zeuzem S., Bechstein W., Mönch C.

Laboratory Immunology and Kidney Transplantation

16 August 2010  /  12:14 - 13:14
102.2
Predicting Outcomes in Kidney Transplantation: A Comparison of Three Semi-Quantitative Proteinuria Tests
Presenter: Bryce Kiberd, Halifax, Canada
Authors: Kiberd B.
102.1
Creatinine and Cystatin C-based Equations for the Estimation of Glomerular Filtration Rate in Kidney Transplantation: Correlation with Histopathology
Presenter: Ender Hur, Izmir, Turkey
Authors: Hur E., Sen C., Nart A., Sen S., Akgun A., Tasli F., Yilmaz M., Uslu A., Toz H.
102.4
Expression of E-cadherin, HSP(Heat Shock Protein)47, TGF-β1 and C4d in Chronic Allograft Nephropathy
Presenter: Samuel Lee, Seoul, Korea
Authors: Lee S., Chung Y., Park J., Kim D., Park S., Kim J., Hyun S., Nam E.
102.3
Glomerulitis during Acute Cellular Rejection May be a Surrogate Marker of Vasculitis in Renal Allografts (Better Index for Diagnosis of Vasculitis)
Presenter: Ping Zhang, Royal Oak, United States
Authors: Zhang P., Farinola M., Samarapungavan D., Rooney M., Hicks S., Cohn S., Reddy G., Rocher L., Dumler F., Parasuraman R.
102.5
Donor-Specific HLA Antibodies Detected by Single Antigen Beads in Renal Transplant Patients: Impact on Clinical Outcome
Presenter: Juha Peräsaari, Helsinki, Finland
Authors: Peräsaari J., Kyllönen L., Salmela K., Merenmies J.
102.7
Biochemical markers of bone turnover and genotyping of polymorphisms and bone densitometry as standard test in the study of bone disease in renal transplant patients.
Presenter: LUISA JIMENO-GARCIA, MURCIA, Spain
Authors: JIMENO-GARCIA L., GONZALEZ-SORIANO M., GIL-DEL CASTILLO L., NOGUERA-VELASCO J., TOVAR-ZAPATA I., MARTINEZ-HERNANDEZ P.
102.8
Bortezomib Therapy for Antibody-Mediated Rejection: Effect on graft function and HLA Donor-Specific Antibody level.
Presenter: Luis Morales-Buenrostro, Mexico City, Mexico
Authors: Morales-Buenrostro L., Leyva S., Marino-Vazquez L., Vega-Vega O., Cantu G.
102.9
A Graded Desensitization Treatment Protocol for Management of Living Donor Recipients with Donor Specific Antibody
Presenter: Richard Knight, Houston, United States
Authors: Patel S., Knight R., Achkar K., Land G., Dilioglou S., Hamilton J., Barretto P., Gaber A.
102.6
A Banff cv2 lesion in a pre-implantation biopsy is the best predictor of delayed graft function following renal transplantation.
Presenter: Benjamin Philosophe, Baltimore, United States
Authors: Munivenkatappa R., Malat G., Soundararajan S., Ranganna K., Drachenberg C., Papadimtriou J., Fayek S., Barth R., Cooper M., David K., Schweitzer E., Bartlett S., Kumar M., Philosophe B.
102.10
C4d binding correlated with strong HLA antibodies can cause graft failure
Presenter: Kazuo Mizutani, Nagoya, Japan
Authors: Mizutani K., Gotoh M., Terasaki P.

Islet and Pancreas Transplantation I

16 August 2010  /  12:14 - 13:14
103.1
Human Islet Isolation Utilizing a Novel Mammalian Tissue Free Enzyme
Presenter: Doug O'Gorman, Edmonton, Canada
Authors: O'Gorman D., Kin T., Imes S., Pawlick R., Senior P., Shapiro J.
103.8
Rapamycin impairs proliferation of transplanted islet beta cells
Presenter: Geraldine Parnaud, Geneva, Switzerland
Authors: Parnaud G., Niclauss N., Bosco D., Berney T.
103.5
A novel approach to prevent early loss of transplanted islets by targeting donor islets with a PPARγ agonist prior to transplantation
Presenter: Toshiyuki Mera, Fukuoka, Japan
Authors: Mera T., Kojima D., Itoh T., Matsuoka N., Ono J., Kodama S., Yasunami Y.
103.2
Factors affecting early graft function in Islet Transplantation
Presenter: David Thompson, Vancouver, Canada
Authors: Thompson D., Ao Z., Meloche M., Shapiro J., Keown P., Paty B., Fung M., Ho S., Almehthel M., Kondi J., Meneilly G., Kozak S., Tong S., Trinh M., Warnock G.